JP2018534946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534946A5 JP2018534946A5 JP2018542687A JP2018542687A JP2018534946A5 JP 2018534946 A5 JP2018534946 A5 JP 2018534946A5 JP 2018542687 A JP2018542687 A JP 2018542687A JP 2018542687 A JP2018542687 A JP 2018542687A JP 2018534946 A5 JP2018534946 A5 JP 2018534946A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- seq
- nucleic acid
- acid sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 7
- 102000040430 polynucleotide Human genes 0.000 claims 7
- 239000002157 polynucleotide Substances 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical group 0.000 claims 6
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- 108091034057 RNA (poly(A)) Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562246841P | 2015-10-27 | 2015-10-27 | |
| US62/246,841 | 2015-10-27 | ||
| PCT/US2016/059151 WO2017075237A2 (en) | 2015-10-27 | 2016-10-27 | Chimeric post-transcriptional regulatory element |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018534946A JP2018534946A (ja) | 2018-11-29 |
| JP2018534946A5 true JP2018534946A5 (https=) | 2019-12-05 |
Family
ID=58561919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542687A Pending JP2018534946A (ja) | 2015-10-27 | 2016-10-27 | キメラ転写後調節要素 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10190135B2 (https=) |
| EP (1) | EP3368672B1 (https=) |
| JP (1) | JP2018534946A (https=) |
| CN (1) | CN108291238A (https=) |
| IL (1) | IL259010A (https=) |
| WO (1) | WO2017075237A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019028273A1 (en) * | 2017-08-02 | 2019-02-07 | Dna2.0, Inc. Dba Atum | DNA VECTORS AND ELEMENTS FOR SUSTAINED GENE EXPRESSION IN EUKARYOTIC CELLS |
| WO2020118169A1 (en) * | 2018-12-07 | 2020-06-11 | Celltheon Corporation | Matrix attachment regions and uses in promoting gene expression |
| CN114207135A (zh) | 2019-06-11 | 2022-03-18 | 夏尔人类遗传性治疗公司 | 用于治疗由失调的血浆激肽释放酶介导的疾病的抗体的腺相关病毒载体递送 |
| WO2021081280A1 (en) | 2019-10-23 | 2021-04-29 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
| WO2022130014A1 (en) | 2020-12-16 | 2022-06-23 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136597A (en) * | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
| US20060019393A1 (en) * | 2003-12-04 | 2006-01-26 | Cannon Paula M | Minimal lentiviral vector system |
| US9943611B2 (en) * | 2012-11-01 | 2018-04-17 | California Institute Of Technology | Reversible gene expression |
| DK3129487T3 (da) * | 2014-04-09 | 2020-11-30 | Dna Twopointo Inc | Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression |
| PL3134432T3 (pl) * | 2014-04-25 | 2020-10-19 | Bluebird Bio, Inc. | Promotor mnd chimeryczne receptory antygenowe |
-
2016
- 2016-10-27 EP EP16860800.8A patent/EP3368672B1/en active Active
- 2016-10-27 WO PCT/US2016/059151 patent/WO2017075237A2/en not_active Ceased
- 2016-10-27 CN CN201680068524.1A patent/CN108291238A/zh active Pending
- 2016-10-27 JP JP2018542687A patent/JP2018534946A/ja active Pending
- 2016-10-27 US US15/335,930 patent/US10190135B2/en active Active
-
2018
- 2018-04-29 IL IL259010A patent/IL259010A/en unknown
- 2018-12-11 US US16/216,636 patent/US20190309322A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018534946A5 (https=) | ||
| JP2012070736A5 (https=) | ||
| JP2011155981A5 (https=) | ||
| JP2017212998A5 (https=) | ||
| JP2010088434A5 (https=) | ||
| JP2016526529A5 (https=) | ||
| EP4306643A3 (en) | Plasmid containing a sequence encoding an mrna with a segmented poly(a) tail | |
| JP2016528887A5 (https=) | ||
| JP2018518163A5 (https=) | ||
| JP2017048194A5 (https=) | ||
| MX2020005458A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| JP2018520997A5 (https=) | ||
| JP2013510581A5 (https=) | ||
| BR112019001887A2 (pt) | composições e métodos para o tratamento de doença associada a cep290 | |
| EA201792663A1 (ru) | Способы скрининга бактерий, архей, водорослей и дрожжей с использованием нуклеиновых кислот crispr | |
| EP4659816A3 (en) | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY | |
| BR112017007737A2 (pt) | variantes de aav recombinantes e usos das mesmas | |
| JP2013530689A5 (https=) | ||
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2008245635A5 (https=) | ||
| MX2018015629A (es) | Sistema de vector viral adeno-asociado traslapado doble para la expresion de abc4a. | |
| JP2017501211A5 (https=) | ||
| JP2012223202A5 (https=) | ||
| CN109983016A (zh) | 嘧啶并[5,4-b]吲嗪或嘧啶并[5,4-b]吡呤化合物、其制备方法及用途 | |
| EP3978614A3 (en) | Single-vector gene construct comprising insulin and glucokinase genes |